Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
pembrolizumab in development Buyback: 6,000 Cr at 1,150/share signals management confidence in long-term value 19) Cipla US - Crossing $400 Mn Quarterly, Ventolin CGT Milestone FY26 US: ~$780 Mn | First AB-rated generic Ventolin with CGT approval Ciplas US business has been built methodically on respiratory leadership (inhaler franchise), and the generic Ventolin approval with Comparative Bioequivalence Study/CGT represents a significant competitive moat
Flexible Spending Accounts (FSA) or Health Savings Accounts (HSA) Many patients use FSA or HSA funds to pay for semaglutide prescriptions, consultations, and related medical supplies
The FDA reevaluated and, in December 2024, upheld its original determination
No pain, just less noise
US$ 26.56
US$ 25.63
US$ 22.17
US$ 28.71
